The 2012 focused update of the European Society of Cardiology for the management of AF state that in a dabigatran-treated patient presenting with an acute coronary syndrome, the concerned clinician may consider the use of a VKA or a factor Xa inhibitor, although there is little evidence to support this approach 48. Here, F10 is linked to atrial fibrillation.